A structure-based approach for targeting the HIV-1 genomic RNA dimerization initiation site

Area of Science:

• Virology
• Structural Biology
• Drug Discovery

Background:

• Genomic RNA dimerization is crucial for Human Immunodeficiency Virus type 1 (HIV-1) replication.
• The Dimerization Initiation Site (DIS) facilitates this dimerization through a specific loop-loop complex formation.
• The DIS structure shares similarities with bacterial 16S ribosomal aminoacyl-tRNA sites targeted by aminoglycosides.

Purpose of the Study:

• To investigate the binding of aminoglycoside antibiotics to the HIV-1 DIS.
• To elucidate the structural basis of the DIS-aminoglycoside interaction.
• To explore potential modifications for enhanced drug affinity and specificity.

Main Methods:

• X-ray crystallography was used to determine the structures of the DIS loop-loop complex.
• Complexes were formed with various aminoglycoside antibiotics.
• Structural analysis focused on the DIS/drug interaction interface.

Main Results:

• The HIV-1 DIS binds several aminoglycoside antibiotics both in vitro and ex vivo.
• Crystal structures reveal detailed interactions between the DIS and bound aminoglycosides.
• Structural insights suggest pathways for improving drug binding characteristics.

Conclusions:

• The structural mimicry between HIV-1 DIS and bacterial A-sites explains aminoglycoside binding.
• Aminoglycosides show potential as antiviral agents targeting HIV-1 RNA dimerization.
• Further structural studies can guide the development of more effective HIV-1 inhibitors.